Compounds > crisnatol
Page last updated: 2024-08-24

crisnatol and Ovarian Neoplasms

crisnatol has been researched along with Ovarian Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buchler, D; Bulkowski, D; Goldstein, D; Hannon, C; Knudsen, C; Smalley, RV; Tuttle, RL1
Baker, LH; Chabot, GG; Lucas, S; Poplin, EA; Tuttle, RL; Wargin, WA1

Trials

2 trial(s) available for crisnatol and Ovarian Neoplasms

ArticleYear
A phase II study of crisnatol mesylate in patients with ovarian carcinoma.
    Investigational new drugs, 1992, Volume: 10, Issue:2

    Topics: Aged; Aged, 80 and over; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Carcinoma; Chrysenes; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms; Propylene Glycols; Treatment Outcome

1992
Crisnatol mesylate: phase I dose escalation by extending infusion duration.
    Investigational new drugs, 1991, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Chrysenes; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasms; Ovarian Neoplasms; Propylene Glycols; Sarcoma

1991